HIV protease inhibitors and onset of cardiovascular diseases: A central role for oxidative stress and dysregulation of the ubiquitin–proteasome system - ScienceDirect
Repurposed Antiviral Drugs for the Treatment of COVID-19: Syntheses, Mechanism of Infection and Clinical Trials | Bentham Science
Therapeutic advances in COVID-19 | Nature Reviews Nephrology
Review of pharmacologic and immunologic agents in the management of COVID-19 | Biosafety and Health
Insights into antiviral mechanisms of remdesivir, lopinavir/ritonavir and chloroquine/hydroxychloroquine affecting the new SARS-CoV-2 - ScienceDirect
Infectious diseases | Nature Reviews Drug Discovery
Remdesivir and its antiviral activity against COVID-19: A systematic review - Clinical Epidemiology and Global Health
Drug repurposing approach to fight COVID-19 | SpringerLink
Life | Free Full-Text | Statins in COVID-19 Therapy
Approaches to the Potential Therapy of COVID-19: A General Overview from the Medicinal Chemistry Perspective
Emerging pharmacotherapies for COVID-19 - ScienceDirect
Why Are Lopinavir and Ritonavir Effective against the Newly Emerged Coronavirus 2019? Atomistic Insights into the Inhibitory Mechanisms | Biochemistry
Paxlovid: Mechanism of Action, Synthesis, and In Silico Study
Frontiers | Combating the Pandemic COVID-19: Clinical Trials, Therapies and Perspectives
HIV Protease Inhibitor Ritonavir Impairs Endothelial Function Via Reduction in Adipose Mass and Endothelial Leptin Receptor‐Dependent Increases in NADPH Oxidase 1 (Nox1), C‐C Chemokine Receptor Type 5 (CCR5), and Inflammation | Journal
Frontiers | Modalities and Mechanisms of Treatment for Coronavirus Disease 2019
Structural biology of SARS-CoV-2: open the door for novel therapies | Signal Transduction and Targeted Therapy
HIV protease inhibitors and nuclear lamin processing: Getting the right bells and whistles | PNAS
SARS-CoV-2 antivirals ~ ViralZone
Oral antiviral treatments for COVID-19: opportunities and challenges | SpringerLink
Why Are Lopinavir and Ritonavir Effective against the Newly Emerged Coronavirus 2019? Atomistic Insights into the Inhibitory Mechanisms | Biochemistry
Frontiers | Mechanism of Action of Small-Molecule Agents in Ongoing Clinical Trials for SARS-CoV-2: A Review
Lopinavir–ritonavir in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial - The Lancet
JKMS :: Journal of Korean Medical Science
Why Are Lopinavir and Ritonavir Effective against the Newly Emerged Coronavirus 2019? Atomistic Insights into the Inhibitory Mechanisms | Biochemistry
How Ritonavir acts as booster drug - YouTube
Epidemic and pandemic viral infections: impact on tuberculosis and the lung | European Respiratory Society
